Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized phase II study of biweekly irinotecan monotherapy or a combination of irinotecan plus 5-fluorouracil/leucovorin (mFOLFIRI) in patients with metastatic gastric adenocarcinoma refractory to or progressive after first-line chemotherapy.
Sym SJ, Hong J, Park J, Cho EK, Lee JH, Park YH, Lee WK, Chung M, Kim HS, Park SH, Shin DB. Sym SJ, et al. Cancer Chemother Pharmacol. 2013 Feb;71(2):481-8. doi: 10.1007/s00280-012-2027-3. Epub 2012 Nov 29. Cancer Chemother Pharmacol. 2013. PMID: 23192279 Clinical Trial.
A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer.
Kim YS, Sym SJ, Park SH, Park I, Hong J, Ahn HK, Park J, Cho EK, Lee WK, Chung M, Lee JH, Shin DB. Kim YS, et al. Among authors: sym sj. Cancer Chemother Pharmacol. 2014 Jan;73(1):163-9. doi: 10.1007/s00280-013-2334-3. Epub 2013 Nov 8. Cancer Chemother Pharmacol. 2014. PMID: 24202666 Clinical Trial.
Low-dose capecitabine plus trastuzumab as first-line treatment in patients 75 years of age or older with HER2-positive advanced gastric cancer: a pilot study.
Kim YS, Sym SJ, Baek MY, Park I, Hong J, Ahn HK, Park J, Cho EK, Lee WK, Chung M, Kim HS, Lee JH, Shin DB. Kim YS, et al. Among authors: sym sj. Cancer Chemother Pharmacol. 2015 Dec;76(6):1267-72. doi: 10.1007/s00280-015-2881-x. Epub 2015 Oct 19. Cancer Chemother Pharmacol. 2015. PMID: 26482716 Clinical Trial.
Concordance Rate between Clinicians and Watson for Oncology among Patients with Advanced Gastric Cancer: Early, Real-World Experience in Korea.
Choi YI, Chung JW, Kim KO, Kwon KA, Kim YJ, Park DK, Ahn SM, Park SH, Sym SJ, Shin DB, Kim YS, Sung KH, Baek JH, Lee U. Choi YI, et al. Among authors: sym sj. Can J Gastroenterol Hepatol. 2019 Feb 3;2019:8072928. doi: 10.1155/2019/8072928. eCollection 2019. Can J Gastroenterol Hepatol. 2019. PMID: 30854352 Free PMC article.
86 results